Adlai Nortye (ANL) Stock Chart & Stock Price History → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free ANL Stock Alerts $13.15 -0.33 (-2.45%) (As of 01:14 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Adlai Nortye Stock Price Performance5 Day Performance-4.57%1 Month Performance+21.76%3 Month Performance+59.59%6 Month Performance+55.62%Year-To-Date Performance+46.27% Receive ANL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ANL Stock Chart for Thursday, May, 9, 2024 ANL Chart by TradingView Adlai Nortye Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$13.57$13.60+0.22%$13.60$13.60290 shs$501.84 million05/07/2024$12.73$13.57+6.60%$13.57$12.64834 shs$500.73 million05/06/2024$13.78$12.73-7.62%$13.80$12.677,267 shs$469.74 million05/03/2024$13.02$13.78+5.84%$13.79$13.403,247 shs$508.48 million05/02/2024$13.01$13.02+0.08%$14.12$11.811,064 shs$480.44 million05/01/2024$13.80$13.01-5.72%$14.13$12.605,159 shs$480.07 million Get the Latest News and Ratings for ANL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$14.80$13.80-6.76%$13.83$13.311,923 shs$509.22 million04/29/2024$13.75$14.80+7.64%$14.90$13.523,552 shs$546.12 million04/26/2024$13.46$13.75+2.15%$13.75$12.038,145 shs$507.38 million04/25/2024$13.55$13.46-0.66%$13.55$12.604,531 shs$496.67 million04/24/2024$13.50$13.55+0.37%$13.55$12.208,059 shs$500.00 million04/23/2024$14.42$13.50-6.38%$14.20$11.4020,869 shs$498.15 million04/22/2024$12.40$14.42+16.29%$15.55$13.1535,510 shs$532.10 million04/19/2024$10.65$12.40+16.43%$12.45$10.3915,908 shs$457.56 million04/18/2024$10.53$10.65+1.14%$10.65$9.803,162 shs$392.99 million04/17/2024$10.53$10.53$10.53$9.574,332 shs$388.56 million04/16/2024$10.95$10.53-3.84%$10.75$9.007,508 shs$388.56 million04/15/2024$10.56$10.95+3.69%$11.20$10.219,059 shs$404.06 million04/12/2024$11.41$10.56-7.45%$11.47$10.553,726 shs$389.66 million04/11/2024$11.40$11.41+0.09%$11.64$10.8610,043 shs$421.03 million04/10/2024$10.80$11.40+5.56%$11.74$10.805,381 shs$420.66 million04/09/2024$12.32$10.80-12.34%$11.99$10.3123,503 shs$398.52 million04/08/2024$8.29$12.32+48.68%$17.48$10.54212,031 shs$454.61 million04/05/2024$10.06$8.29-17.63%$11.13$7.657,806 shs$305.76 million04/04/2024$9.74$10.06+3.29%$10.19$9.515,874 shs$371.21 million04/03/2024$9.55$9.74+1.99%$9.74$9.552,308 shs$359.41 million04/02/2024$9.40$9.55+1.60%$9.60$9.154,501 shs$352.40 million04/01/2024$8.88$9.40+5.87%$9.40$8.904,413 shs$346.86 million03/29/2024$8.88$8.88-0.01%$8.88$8.88355 shs$327.63 million03/28/2024$9.14$8.88-2.84%$8.88$8.88355 shs$327.67 million03/27/2024$8.91$9.14+2.58%$9.14$9.14333 shs$337.27 million03/26/2024$8.55$8.91+4.21%$9.08$8.811,200 shs$328.78 million03/25/2024$9.03$8.55-5.32%$9.01$8.552,863 shs$315.50 million03/22/2024$8.51$9.03+6.11%$9.03$9.03283 shs$333.21 million03/21/2024$9.10$8.51-6.48%$9.10$8.511,767 shs$314.02 million03/20/2024$9.10$9.10$9.10$8.95544 shs$335.79 million03/19/2024$9.03$9.10+0.83%$9.10$8.95544 shs$335.79 million03/18/2024$9.00$9.03+0.28%$9.10$8.352,513 shs$333.02 million03/15/2024$9.01$9.00-0.11%$9.05$8.96631 shs$332.10 million03/14/2024$8.99$9.01+0.22%$9.01$8.621,409 shs$332.47 million1970’s computer coder Issues Shocking AI Warning (Ad)Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP03/13/2024$8.64$8.99+4.05%$8.99$8.841,040 shs$331.73 million03/12/2024$8.76$8.64-1.38%$8.86$8.341,687 shs$318.82 million03/11/2024$7.65$8.76+14.52%$8.76$8.681,156 shs$323.27 million03/08/2024$7.75$7.65-1.29%$7.65$7.15670 shs$282.29 million03/07/2024$7.55$7.75+2.65%$7.75$7.75461 shs$285.98 million03/06/2024$7.61$7.55-0.79%$8.00$7.55119 shs$278.60 million03/05/2024$8.10$7.61-6.05%$7.80$7.251,643 shs$280.81 million03/04/2024$7.90$8.10+2.53%$8.70$7.647,241 shs$298.89 million03/01/2024$7.15$7.90+10.49%$8.27$7.556,389 shs$291.51 million02/29/2024$7.15$7.15$7.15$7.15599 shs$263.84 million02/28/2024$7.15$7.15$7.15$7.15112 shs$263.84 million02/27/2024$7.15$7.15$7.15$7.1552 shs$263.84 million02/26/2024$7.15$7.15-0.01%$7.30$7.15615 shs$263.84 million02/23/2024$7.11$7.15+0.56%$7.59$7.152,665 shs$263.84 million02/22/2024$7.51$7.11-5.33%$7.11$7.11380 shs$262.36 million02/21/2024$7.60$7.51-1.18%$7.51$7.51491 shs$277.12 million02/20/2024$7.39$7.60+2.84%$7.74$7.60594 shs$280.44 million02/19/2024$7.39$7.39$7.46$7.39500 shs$272.69 million02/16/2024$7.39$7.39$7.46$7.39567 shs$272.69 million02/15/2024$7.25$7.39+1.93%$7.46$7.39567 shs$272.69 million02/14/2024$7.25$7.25$7.33$7.25769 shs$267.53 million02/13/2024$8.24$7.25-12.01%$7.33$7.25459 shs$267.53 million02/12/2024$8.24$8.24$8.24$8.24369 shs$304.06 million02/09/2024$8.86$8.24-7.00%$8.24$7.501,741 shs$304.06 million02/08/2024$8.90$8.86-0.45%$8.86$8.78345 shs$326.93 million Related Companies: Arbutus Biopharma Stock Price Chart Fulcrum Therapeutics Stock Price Chart Larimar Therapeutics Stock Price Chart PepGen Stock Price Chart Travere Therapeutics Stock Price Chart Korro Bio Stock Price Chart Entrada Therapeutics Stock Price Chart Neurogene Stock Price Chart Theravance Biopharma Stock Price Chart Altimmune Stock Price Chart Receive ANL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adlai Nortye Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.